Related Experiment Videos
Inhibited angiogenesis in aging: a role for TIMP-2
Teruhiko Koike1, Robert B Vernon, Michel D Gooden
1Department of Medicine, University of Washington, Seattle, Washington 98104, USA.
Summary
Aging impairs blood vessel formation due to increased tissue inhibitor of metalloproteinases-2 (TIMP-2). This molecule inhibits matrix metalloproteinases (MMP-2), reducing the ability of cells to form new blood vessels.
Area of Science:
- Cell Biology
- Biochemistry
- Aging Research
Background:
- Age-associated impairment of angiogenesis is not well understood.
- Angiogenesis, the formation of new blood vessels, is crucial for tissue repair and development.
Purpose of the Study:
- To investigate the molecular factors contributing to age-related decline in angiogenesis.
- To determine the role of tissue inhibitor of metalloproteinases-2 (TIMP-2) and matrix metalloproteinases (MMPs) in age-associated angiogenesis impairment.
Main Methods:
- Comparison of angiogenesis in young and aged mice using polyvinyl alcohol sponges.
- In vitro studies using young (hmEC36) and aged (hmEC90) human microvascular endothelial cells cultured in collagen.
- Assessment of cell morphogenetic capacity, tubulogenesis, and expression of TIMP-2, TIMP-1, MMP-2, and MT1-MMP.
- Inhibition studies using GM6001 (MMP inhibitor) and purified TIMP-2.
Main Results:
- Aged mice exhibited increased TIMP-2 expression in new vascular tissue.
- Aged endothelial cells (hmEC90) showed reduced tubulogenesis and lower active MMP-2 expression compared to young cells (hmEC36).
- TIMP-2 levels were higher in aged cells, and purified TIMP-2 inhibited tubulogenesis in young cells, suggesting TIMP-2's inhibitory role.
Conclusions:
- Elevated TIMP-2 levels are a key factor in age-associated angiogenesis impairment.
- TIMP-2 likely inhibits angiogenesis by suppressing the activity of MMP-2 and MT1-MMP.
- Targeting TIMP-2 or MMPs could potentially restore angiogenic capacity in aged tissues.